Zheng Yu Y - OmicsDI

Show results for

Unknown (4589)
Proteomics (146)
Metabolomics (24)
Transcriptomics (18)
Genomics (9)
Multiomics (3)
Models (2)

Organisms

Aerococcus urinae NBRC 15544 = CCUG 36881 (67)
Alteromonadales (67)
Bacteria (67)
Canis lupus familiaris (67)
Carya cathayensis (67)
Ectopseudomonas oleovorans CECT 5344 (67)
Ensifer adhaerens (67)
Enterococcus faecalis (67)
Globicatella sanguinis (67)
Halictus scabiosae (67)
Homo sapiens (66)
Mus musculus (15)
Rattus norvegicus (4)
cellular organisms (3)
Arabidopsis thaliana (3)
Drosophila melanogaster (2)
Oryctolagus cuniculus (2)
Bacillus thuringiensis (1)
Oryza sativa Japonica Group (1)
Carassius gibelio (1)
Danio rerio (1)
Enterococcus faecalis (1)
Macrothele (1)
Manihot esculenta (1)
Rattus rattus (1)
Severe acute respiratory syndrome coronavirus 2 (1)
Solanum lycopersicum (1)
Spodoptera frugiperda (1)
Staphylococcus aureus (1)
unclassified Sparassidae (1)

Repository

iProX (72)
pride (67)
MetaboLights (24)
biostudies-arrayexpress (20)
EGA (7)
jPOST (3)
PeptideAtlas (3)
BioModels (2)
MassIVE (1)

Tissue

Cell culture (21)
Epithelial cell (5)
Blood (4)
Brain (4)
Liver (4)
Others (3)
Blood plasma (3)
Heart (3)
Sperm (3)
Stem cell (3)
Testis (3)
Embryonic stem cell (2)
Permanent cell line cell (2)
Spleen (2)
Whole body (2)
Adrenal gland (1)
B cell (1)
Blood cell (1)
Bone marrow (1)
Bone matrix (1)
Breast (1)
Burkitt lymphoma cell (1)
Cell suspension culture (1)
Colon (1)
Diploid cell (1)
Esophagus (1)
Fat body (1)
Flower (1)
Gall bladder (1)
HeLa cell (1)

Disease

Colon cancer (2)
Disease free (2)
Type 2 diabetes mellitus (2)
VSV infection (1)
Cervix carcinoma (1)
Cognitive disorder (1)
Lung carcinoma (1)
Polycystic Kidney (1)

Technology Type

Mass Spectrometry (67)
Shotgun proteomics (24)
Mass spectrometry (22)
Bottom-up proteomics (12)
Affinity purification coupled with mass spectrometry proteomics (10)
Data-independent acquisition (9)
Data-dependent acquisition (7)
Gel-based experiment (6)
Top-down proteomics (4)
NMR spectroscopy (2)
SRM/MRM (2)
SWATH MS (2)
Illumina Genome Analyzer II, Illumina HiSeq 2000 (1)
Chemical cross-linking coupled with mass spectrometry proteomics (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (9)
Liquid Chromatography MS - positive - reverse phase (9)
Liquid Chromatography MS - negative (3)
Liquid Chromatography MS - positive (3)
Bruker (2)
Liquid Chromatography MS - alternating - hilic (2)
Liquid Chromatography MS - alternating - reverse phase (2)
Liquid Chromatography MS - positive - hilic (2)
LTQ Orbitrap Elite (2)
Illumina HiSeq 2000 (1)
Q Exactive mass spectrometer (Thermo Scientific) (1)
Liquid Chromatography MS - Negative (LC-MS (NEG)) (1)
Liquid Chromatography MS - Positive (LC-MS (POS)) (1)
Liquid Chromatography MS - alternating – hilic (1)
6530 Q-TOF LC/MS (Agilent) (1)
Gas Chromatography MS - (1)
Liquid Chromatography MS - Negative (LC-MS (Negative)) (1)
Liquid Chromatography MS - Positive (LC-MS (Positive)) (1)
Liquid Chromatography MS - (1)
Liquid Chromatography MS - negative - hilic (1)
QExactive (1)

Publication Date

2025 (34)
2024 (28)
2023 (24)
2022 (23)
2021 (17)
2020 (13)
2019 (12)
2026 (11)
2010 (7)
2014 (6)
2015 (3)
2012 (3)
2018 (3)
2017 (3)
2013 (2)
2016 (1)
2011 (1)
2009 (1)

UNIPROT ID/AC

A0A024R563 (3)
A0A024R8H9 (3)
A0A024RAN2 (3)
A0A024RC46 (3)
A0A087WUD1 (3)
A0A087WVZ5 (3)
A0A087WWK8 (3)
A0A087WXI0 (3)
A0A087WZE9 (3)
P17676 (2)
P15260 (2)
Q06124 (2)
P62136 (2)
P67775 (2)
Q07889 (2)
P08887 (2)
P40189 (2)
P01579 (2)
O15524 (2)
O14543 (2)
P42224 (2)
P40763 (2)
O60674 (2)
P23458 (2)
P28482 (2)
Q02750 (2)
P04049 (2)
P01112 (2)
P05231 (2)
P62993 (2)

ENSEMBL ID

ENSG00000147251 (3)
ENSG00000170477 (3)
ENSG00000247315 (3)

CHEBI ID

CHEBI:16870 (10)
CHEBI:16919 (9)
CHEBI:55328 (8)
CHEBI:16704 (8)
CHEBI:15891 (8)
CHEBI:18132 (8)
CHEBI:17154 (8)
CHEBI:16737 (8)
CHEBI:16708 (7)
CHEBI:28834 (7)
CHEBI:17750 (7)
CHEBI:17509 (7)
CHEBI:15741 (7)
CHEBI:17015 (7)
CHEBI:32816 (7)
CHEBI:16347 (7)
CHEBI:17368 (7)
CHEBI:17748 (6)
CHEBI:16393 (6)
CHEBI:27823 (6)
CHEBI:17859 (6)
CHEBI:16359 (6)
CHEBI:76308 (6)
CHEBI:24813 (6)
CHEBI:17533 (6)
CHEBI:73722 (6)
CHEBI:17821 (6)
CHEBI:16040 (6)
CHEBI:15843 (6)
CHEBI:17203 (6)

Metabolite Name

Guanine (5)
N-Acetyl-L-phenylalanine (5)
Creatine (5)
Glycerophosphocholine (5)
Betaine (4)
Thymine (4)
Choline (4)
Taurine (4)
Cytosine (4)
Riboflavin (4)
Guanosine (4)
Uridine (4)
Creatinine (4)
L-Carnitine (4)
Hypoxanthine (4)
LysoPE(0:0/18:3(6Z,9Z,12Z)) (3)
L-Pipecolic acid (3)
LysoPE(16:0/0:0) (3)
LysoPC(14:0/0:0) (3)
Stearoylcarnitine (3)
Isonicotinic acid (3)
Valine (3)
Sphingosine (3)
Benzaldehyde (3)
Argininosuccinic acid (3)
Pantothenol (3)
DL-2-Aminooctanoic acid (3)
7-Methylguanine (3)
Valyl-Isoleucine (3)
Proline betaine (3)

IsPrivate

False (2)

Modelling Approach

Ordinary differential equation model (2)

Modification

-17.026549 (1)
15.994915 (1)
57.021464 (1)

Study type

Transcription profiling by array (8)
RNA-seq of coding RNA (8)
Other (1)
ChIP-seq (1)
MicroRNA profiling by array (1)
Methylation profiling by high throughput sequencing (1)

Release Date

2025 (784)
2022 (659)
2023 (544)
2024 (523)
2021 (521)
2020 (375)
2019 (267)
2018 (188)
2017 (156)
2016 (128)
2026 (121)
2015 (117)
2014 (79)
2013 (42)
2012 (38)
2010 (27)
2011 (13)
2009 (7)
2007 (5)
2005 (5)
2008 (4)
2004 (4)
2006 (1)
2002 (1)

Lab affiliation

Tsinghua University, China (4)
China Agricultural University, College of Animal Science and Technolgoy, Animal genetics and breeding (2)
Department of Physiology & Biophysics, University of California, Irvine, Irvine, California, USA (2)
1 Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China. 2 Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China. 3 State Key Laboratory Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China. (1)
1Cancer Institute, the Second Affiliated Hospital, and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou 310029, China 2Cancer Center, Zhejiang University, Hangzhou 310058, China 3Research Center for Life Science and Human Health, Binjiang Institute of Zhejiang University, Hangzhou 310053, China (1)
1Department of Pathology, Dana-Farber/Harvard Cancer Center, PhD Program in Immunology, Harvard Medical School; Department of Laboratory Medicine, Boston Children's Hospital, Enders Research Building, Room 811, Boston, MA, 02115, USA (1)
1Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA 2Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA 3Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA (1)
Bengbu Medical University (1)
Biochemistry and Structural Biology Greehey Children's Cancer Research Institute University of Texas Health at San Antonio United States (1)
China Agricultural University (West Campus) College of Animal Science and Technology (1)
Chongqing Medical University (1)
Department of Analytical Chemistry and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences (1)
Department of Biology, University of Florida (1)
Department of Clinical Laboratory Medicine, Shanghai Tenth People’s Hospital of Tongji University, Shanghai, 200072, China (1)
Department of Human Anatomy, Histology and Embryology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology (1)
Department of Infectious Diseases and the Key Lab of Endogenous Infection, Shenzhen Nanshan People's Hospital and The 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen 518052, China (1)
Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, Hu Bei Province, 430060, China (1)
Department of Ophthalmology, Shanghai General Hospital; Shanghai Key Laboratory of Ocular Fundus Disease; Shanghai Engineering Center for Visual Science and Photomedicine, No. 100 Haining Road, Shanghai 200080, China. (1)
Department of Orthopedics, the Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen 518003, P.R. China (1)
Department of Parasitology, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China (1)
Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University (1)
Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine (SJTU-SM), Shanghai 200025, China. (1)
Department of Pathophysiology, Key Laboratory of Ministry of Education for Neurological Disorders, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology (1)
Department of orthopaedics, the First Affiliated Hopital of Soochow University, Suzhou, China 215006 (1)
Dezhou University (1)
Fujian Agriculture and Forestry University (1)
Hangzhou Medical College (1)
Huazhong University of Science and Technology (1)
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, USA (1)
Institute of Marine Sciences and Guangdong Provincial Key Laboratory of Marine Biotechnology, Shantou University, Shantou 515063, China (1)

Previous page
1 / 479
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 479
Next page

Sort by:

Relevance

Page size

Fu Zheng Xiao Yu San Jie Decoction affects the proliferation of renal cell carcinoma via regulating <i>E2F5</i> gene.

Not available

S-EPMC12779431 | biostudies-literature

Metabolite signatures of diverse Camellia sinensis tea populations

Tea plants (Camellia sinensis) present an excellent system to study evolution and diversification of specialized metabolites due to their abundance in classes, numbers and contents. A large number of tea cultivars have been cultivated throughout the world not only because of their adaption to differ...

2020-10-05 | MTBLS1405 | MetaboLights

NMR based metabolomics study of Y2 receptor activation by neuropeptide Y in the SK-N-BE2 human neuroblastoma cell line

Neuropeptide Y (NPY) and its Y2 receptors (Y2R) play an important role in regulating growth of various tumors and are highly expressed in human neuroblastoma brain tumors. Cell lines derived from neuroblastoma brain tumors provide a good model to study the consequences of NPY activation of Y2R in tu...

2014-10-01 | MTBLS104 | MetaboLights

Validation of the Anticolitis Efficacy of the Jian-Wei-Yu-Yang Formula.

Not available

S-EPMC9451982 | biostudies-literature

The ratio of dihomo-γ-linolenic acid to deoxycholic acid species is a potential biomarker for the metabolic abnormalities in obesity.

Not available

S-EPMC6191069 | biostudies-literature

Research Progress on Classical Traditional Chinese Medicine Jieyu Pills in the Treatment of Depression.

Not available

S-EPMC7733407 | biostudies-literature

A Chinese Prescription Yu-Ping-Feng-San Administered in Remission Restores Bronchial Epithelial Barrier to Inhibit House Dust Mite-Induced Asthma Recurrence.

Not available

S-EPMC7006455 | biostudies-literature

Hyocholic acid species as novel biomarkers for metabolic disorders

Hyocholic acid (HCA) is a major bile acid (BA) species in the BA pool of pigs, a species known for its exceptional resistance to spontaneous development of diabetic phenotypes. HCA and its derivatives are also present in human blood and urine. We investigate whether human HCA profiles can predict th...

2021-10-06 | MTBLS2343 | MetaboLights

Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis

Zhuyu pill (ZYP) is a traditional Chinese medicine prescription composed of two drugs, Coptis chinensis Franch. and Tetradium ruticarpum (A. Jussieu) T. G. Hartley, and is commonly used in the clinical treatment of diseases of the digestive system. However, the mechanism underly...

2022-11-02 | MTBLS4980 | MetaboLights

Food withdrawal alters the gut microbiota and metabolome in mice.

Not available

S-EPMC9292403 | biostudies-literature

Previous page
1 / 479
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 479
Next page

Sort by:

Relevance

Page size

4788 Results

Show results for

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

UNIPROT ID/AC

ENSEMBL ID

CHEBI ID

Metabolite Name

IsPrivate

Modelling Approach

Modification

Study type

Release Date

Lab affiliation

OmicsDI is part of the ELIXIR infrastructure

Tweets